ES2118664T3 - Nuevo derivado de la 4-imidazolidinona y su utilizacion como agonista del receptor de nmda. - Google Patents

Nuevo derivado de la 4-imidazolidinona y su utilizacion como agonista del receptor de nmda.

Info

Publication number
ES2118664T3
ES2118664T3 ES96402661T ES96402661T ES2118664T3 ES 2118664 T3 ES2118664 T3 ES 2118664T3 ES 96402661 T ES96402661 T ES 96402661T ES 96402661 T ES96402661 T ES 96402661T ES 2118664 T3 ES2118664 T3 ES 2118664T3
Authority
ES
Spain
Prior art keywords
imidazolidinone
receptor agonist
nmda receptor
new derivative
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96402661T
Other languages
English (en)
Inventor
Alex Cordi
Jean-Michel Lacoste
Mark Millan
Valerie Audinot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADIR SARL
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Application granted granted Critical
Publication of ES2118664T3 publication Critical patent/ES2118664T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

COMPUESTO DE FORMULA (I): ASI COMO SUS SALES DE ADICION A UN ACIDO O A UNA BASE FARMACEUTICAMENTE ACEPTABLE.
ES96402661T 1995-12-21 1996-12-09 Nuevo derivado de la 4-imidazolidinona y su utilizacion como agonista del receptor de nmda. Expired - Lifetime ES2118664T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9515223A FR2742748B1 (fr) 1995-12-21 1995-12-21 Nouveau derive de 4-imidazolidinone, son procede de preparation et les compositions pharmaceutiques qui le contiennent

Publications (1)

Publication Number Publication Date
ES2118664T3 true ES2118664T3 (es) 1998-09-16

Family

ID=9485771

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96402661T Expired - Lifetime ES2118664T3 (es) 1995-12-21 1996-12-09 Nuevo derivado de la 4-imidazolidinona y su utilizacion como agonista del receptor de nmda.

Country Status (14)

Country Link
US (1) US5677325A (es)
EP (1) EP0780379B1 (es)
JP (1) JPH09176128A (es)
CN (1) CN1067381C (es)
AT (1) ATE165349T1 (es)
AU (1) AU705695B2 (es)
CA (1) CA2193310C (es)
DE (1) DE69600253T2 (es)
DK (1) DK0780379T3 (es)
ES (1) ES2118664T3 (es)
FR (1) FR2742748B1 (es)
NO (1) NO305753B1 (es)
NZ (1) NZ299984A (es)
ZA (1) ZA9610804B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6347197B1 (en) * 2000-10-20 2002-02-12 Lexmark International, Inc. Life determination in an oil web system
JP3891484B2 (ja) * 2002-09-05 2007-03-14 株式会社ノリタケカンパニーリミテド 電解質膜およびその膜を備えた燃料電池

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904681A (en) * 1987-12-01 1990-02-27 G. D. Searle & Co. D-cycloserine and its prodrugs as cognitive enhancers

Also Published As

Publication number Publication date
NO965445L (no) 1997-06-23
CA2193310A1 (fr) 1997-06-22
NO965445D0 (no) 1996-12-18
ZA9610804B (en) 1997-06-30
CN1158847A (zh) 1997-09-10
CA2193310C (fr) 2001-08-14
CN1067381C (zh) 2001-06-20
AU7547996A (en) 1997-06-26
FR2742748A1 (fr) 1997-06-27
EP0780379A1 (fr) 1997-06-25
DK0780379T3 (da) 1999-01-25
NO305753B1 (no) 1999-07-19
JPH09176128A (ja) 1997-07-08
DE69600253D1 (de) 1998-05-28
EP0780379B1 (fr) 1998-04-22
ATE165349T1 (de) 1998-05-15
DE69600253T2 (de) 1998-11-12
NZ299984A (en) 1997-11-24
US5677325A (en) 1997-10-14
FR2742748B1 (fr) 1998-01-30
AU705695B2 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
ES2146718T3 (es) Derivados del acido pirrolidinadicarboxilico como agonistas de receptores metabotropicos de glutamato.
DE69527072D1 (de) Endothelin antagoniste
PT865281E (pt) Derivados de benzimidazole substituidos por naftilo como anticoagulantes
PT1177176E (pt) Derivados de acidos triarilicos como ligandos de receptores ppar.
ES2070660B1 (es) Un procedimiento para la preparacion de 2,5-damino-3-hidroxihexanos sustituidos, utiles como inhibidores de proteasas retrovirales.
ES2138983T3 (es) Uso de derivados del acido 2-(n-(2-aminoetil)amino)-acetico para el tratamiento de enfermedades condicionadas por glicosilacion no enzimatica.
SE7905009L (sv) Ny l-gamma-glutamyl-3-karboxi-4-hydroxianilid och salter derav
BR9714650A (pt) " derivados farmacêuticos de ácido aminofosfÈnico "
ES2071325T3 (es) Derivados de 4-alquilimidazol.
ES2187261A1 (es) Compuestos de eteres y amidas y su preparacion, como agentes anti-diabeticos.
ATE116000T1 (de) Lichtaktivierte acylenzyme.
DK0538192T3 (da) Hidtil ukendte 17beta-substituerede aza-androstan-derivater
TR199800531T1 (xx) NMDA antagonistleri olarak tetrahidrokinolinler.
ES2145021T3 (es) Derivados de 1-bifenil-piridona, su preparacion y su uso como antagonistas de la angiotensina ii.
ES2118664T3 (es) Nuevo derivado de la 4-imidazolidinona y su utilizacion como agonista del receptor de nmda.
DE69327890D1 (de) Verfahren zur Herstellung von 2-(un)substituierten 4-Alkylimidazolen
ES525256A0 (es) Procedimiento para la obtencion de 2-nitro-1,1-etendiaminas
EA199800189A1 (ru) Оптически активное производное фенилпиримидина в качестве анальгетика
AR003924A1 (es) Bencensulfonilureas y bencensulfoniltioureas sustituidas, procedimiento para su preparacion, empleo de las mismas y agente curativo que las contiene
ES2056639T3 (es) Procedimiento para la transformacion del acido (benzoil-3 fenil)-2 propionico-r(-) en isomero s(+).
ES2106058T3 (es) Derivados de benzamida.
AR005453A1 (es) Proceso para la preparacion de 1,2,4-triazolin-3(2h)-onas herbicidas altamente activas e intermediarios utiles para llevar a cabo dicho proceso
ATE194346T1 (de) Stabile wässrige folinatlösung
ES2062066T3 (es) Derivados de la piperacina y su procedimiento de preparacion.
ES2146772T3 (es) Derivados de imidoacidos y su empleo como pesticidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 780379

Country of ref document: ES